HRT Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,232
Closed -$2.51M 4353
2025
Q4
$2.52M Buy
+26,232
New +$2.55M 0.01% 1154
2025
Q3
Sell
-216,444
Closed -$18.9M 3338
2025
Q2
$18.9M Buy
+216,444
New +$18.4M 0.08% 162
2025
Q1
Sell
-68,610
Closed -$5.48M 3035
2024
Q4
$5.48M Sell
68,610
-812,772
-92% -$70.4M 0.03% 376
2024
Q3
$79.3M Buy
881,382
+796,705
+941% +$67M 0.39% 26
2024
Q2
$6.66M Buy
84,677
+34,954
+70% +$2.87M 0.04% 318
2024
Q1
$4.33M Sell
49,723
-23,049
-32% -$1.97M 0.03% 303
2023
Q4
$5.99M Buy
72,772
+11,198
+18% +$853K 0.04% 247
2023
Q3
$4.82M Sell
61,574
-49,312
-44% -$4.13M 0.05% 311
2023
Q2
$9.77M Buy
110,886
+103,564
+1,414% +$8.92M 0.09% 149
2023
Q1
$590K Sell
7,322
-68,042
-90% -$5.55M 0.01% 1248
2022
Q4
$5.86M Buy
+75,364
New +$6.11M 0.08% 221
2021
Q4
Sell
-113,087
Closed -$14.2M 3710
2021
Q3
$14.2M Buy
+113,087
New +$14.6M 0.09% 111
2021
Q2
Sell
-7,827
Closed -$924K 3253
2021
Q1
$924K Sell
7,827
-81,549
-91% -$9.56M 0.01% 1241
2020
Q4
$10.5M Buy
+89,376
New +$9.84M 0.21% 83
2020
Q3
Sell
-52,671
Closed -$4.83M 2181
2020
Q2
$4.83M Buy
52,671
+18,123
+52% +$1.74M 0.15% 127
2020
Q1
$3.12M Buy
+34,548
New +$3.68M 0.2% 92
2019
Q3
Sell
-2,230
Closed -$217K 1514
2019
Q2
$217K Sell
2,230
-6,618
-75% -$604K 0.01% 611
2019
Q1
$805K Buy
8,848
+5,104
+136% +$457K 0.12% 120
2018
Q4
$340K Buy
3,744
+1,662
+80% +$155K 0.05% 312
2018
Q3
$204K Sell
2,082
-535
-20% -$49.5K 0.03% 328
2018
Q2
$224K Buy
+2,617
New +$219K 0.08% 189
2018
Q1
Sell
-3,082
Closed -$248K 235
2017
Q4
$248K Buy
+3,082
New +$247K 0.25% 67

Other funds holding MDT

HRT Financial's MDT Position: Q1 2026 in Review

HRT Financial sold out of Medtronic (MDT) in Q1 2026, closing a stake of 26,232 shares — an estimated $2.51M sold.

HRT Financial first reported a position in MDT in Q4 2017 and held it in 22 quarters. The position peaked at $79.3M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • HRT Financial reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 26,232 Medtronic shares in Q1 2026, an estimated $2.51M.
  • HRT Financial first reported a position in Medtronic in Q4 2017 and held it in 22 quarters.
  • HRT Financial's Medtronic position peaked at $79.3M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.